Experimental group:Tirofiban

5 trials

Sponsors

The Affiliated Weihai Central Hospital of Qingdao University, The Second Affiliated Hospital of the Army Medical University, Capital Medical University Affiliated Beijing Anzhen Hospital, The Sixth Affiliated Hospital of Jinan University, Tongji Hospital, Tongji Medical College ,Huazhong University of Science and Technology

Conditions

Acute ischemic strokeacute ischemic strokecoronary heart disease

Phase 3

Safety and efficacy of adjunct tirofiban treatment after successful mechanical thrombectomy recanalization in acute anterior circulation ischemic stroke— A Multicenter, Prospective, Double-blind, Randomized Trial

RecruitingChiCTR2500105242

Tongji Hospital, Tongji Medical College ,Huazhong University of Science and Technologyacute ischemic stroke

Start: 2024-04-09Updated: 2025-07-07

Phase 4

A prospective, multicenter, randomized controlled trial for tirofiban in the early treatment of acute ischemic stroke

Active, not recruitingChiCTR2000029502

The Second Affiliated Hospital of the Army Medical UniversityAcute ischemic stroke

Start: 2020-10-20Updated: 2023-03-12

Prospective study of tirofiban in the prevention of early progression of acute non-large vessel occlusions cerebral infarction

RecruitingChiCTR2200061110

The Sixth Affiliated Hospital of Jinan UniversityAcute ischemic stroke

Start: 2022-09-01Updated: 2023-03-26

Unknown Phase

Clinical efficacy and safety of clofibroxaol in the treatment of non-thrombolytic cerebral infarction and transient ischemic attack: a real-world retrospective study based on case database

Active, not recruitingChiCTR1900025936

The Affiliated Weihai Central Hospital of Qingdao Universityacute ischemic stroke

Start: 2019-10-01Updated: 2019-12-16

Tirofiban versus heparin bridged with antiplatelet for the prevention of major cardiovascular and cerebrovascular events in patients undergoing coronary endarterectomy combined with coronary artery bypass grafting

RecruitingChiCTR2200055697

Capital Medical University Affiliated Beijing Anzhen Hospitalcoronary heart disease

Start: 2022-09-01Updated: 2023-06-26

Related Papers

Tirofiban for Preventing Early Neurological Deterioration in Acute Ischemic Stroke Within 48 Hours of Onset: Evidence From a Dual-Method Analysis Using Propensity Score Matching and Multivariable Regression.

2025-12-011 citations

Early tirofiban versus heparin for bridging dual antiplatelet therapy in patients undergoing coronary endarterectomy combined with coronary artery bypass grafting: a multicenter randomized controlled trial protocol (the THACE-CABG trial)

Trials2024-01-154 citations

Tirofiban for Stroke without Large or Medium-Sized Vessel Occlusion

New England Journal of Medicine2023-05-3188 citations

RESCUE BT 2, a multicenter, randomized, double-blind, double-dummy trial of intravenous tirofiban in acute ischemic stroke: Study rationale and design

International Journal of Stroke2022-08-224 citations